Monday, October 31, 2011 4:33:45 PM
And I suppose you believe that 10% is the appropriate volatility to use for CPRX?
Though there is no implied volatility for CPRX because no options are currently available, the historical volatility is 79.7%, vs Ariad's which is 65.3%.
Therefore, it's clear that if there were CPRX options, the implied vol would be higher than Ariad's(I really only used the same vol estimate for both to give your calculation the benefit of the doubt).
Therefore, it's also obvious that any kind of rational estimate of CPRX's Black Scholes warrant value would require the use of a higher Volatility value than Ariad's, leading to a higher call price estimate.
For example, if you used 70%, the result is $.75, or 75%(probably closer), the result would be $.78.
Picking 10% vol out of the air(since it bears no relation to the stock's volatility) is what's really flawed.
What's also really flawed is your apparent inability to fairly entertain and consider different viewpoints.
Like you said:
Though there is no implied volatility for CPRX because no options are currently available, the historical volatility is 79.7%, vs Ariad's which is 65.3%.
Therefore, it's clear that if there were CPRX options, the implied vol would be higher than Ariad's(I really only used the same vol estimate for both to give your calculation the benefit of the doubt).
Therefore, it's also obvious that any kind of rational estimate of CPRX's Black Scholes warrant value would require the use of a higher Volatility value than Ariad's, leading to a higher call price estimate.
For example, if you used 70%, the result is $.75, or 75%(probably closer), the result would be $.78.
Picking 10% vol out of the air(since it bears no relation to the stock's volatility) is what's really flawed.
What's also really flawed is your apparent inability to fairly entertain and consider different viewpoints.
Like you said:
...basically garbage in, garbage out.
Recent CPRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 09:23:18 PM
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance • GlobeNewswire Inc. • 02/25/2026 09:07:55 PM
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference • GlobeNewswire Inc. • 02/24/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 10:04:15 PM
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:03:17 PM
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies • GlobeNewswire Inc. • 01/08/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:30 PM
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) • GlobeNewswire Inc. • 01/05/2026 01:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/30/2025 10:00:15 PM
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/15/2025 01:03:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/12/2025 09:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2025 10:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 10:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 06:54:26 PM
